What Happened?
Simpsonville, SC-based Elastrin-Therapeutics Appointed Matthias Breugelmans as Chief Executive Officer
About the Company
Elastrin Therapeutics is a South Carolina-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice.
About the Person
Matthias Breugelmans is Chief Executive Officer at Elastrin Therapeutics. Previously, Matthias held various senior HR leadership roles in the industry.
Info Source
News
Short Profile